• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定平均乳腺癌风险女性的风险阈值,以实现有组织的筛查计划的个体化。

Determination of thresholds of risk in women at average risk of breast cancer to personalize the organized screening program.

机构信息

Montpellier University, EA2415, Institut Universitaire de recherche clinique, 34093, Montpellier Cedex 5, France.

Languedoc Mutualité, Nouvelles Technologies, AESIO, Montpellier, France.

出版信息

Sci Rep. 2021 Sep 27;11(1):19104. doi: 10.1038/s41598-021-98604-6.

DOI:10.1038/s41598-021-98604-6
PMID:34580360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8476568/
Abstract

In France, more than 10 million women at "average" risk of breast cancer (BC), are included in the organized BC screening. Existing predictive models of BC risk are not adapted to the French population. Thus, we set up a new score in the French Hérault region and looked for subgroups at a graded level of risk in women at "average" risk. We recruited a retrospective cohort of women, aged 50 to 60, who underwent the organized BC screening, and included 2241 non-cancer women and 527 who developed a BC during a 12-year follow-up period (2006-2018). The risk factors identified were high breast density (ACR BI-RADS grading)(B vs A: HR = 1.41, 95%CI [1.05; 1.9], p = 0.023; C vs A: HR = 1.65 [1.2; 2.27], p = 0.02 ; D vs A: HR = 2.11 [1.25;3.58], p = 0.006), a history of maternal breast cancer (HR = 1.61 [1.24; 2.09], p < 0.001), and socioeconomic difficulties (HR 1.23 [1.09; 1.55], p = 0.003). While early menopause (HR = 0.36 [0.13; 0.99], p = 0.003) and an age at menarche after 12 years (HR = 0.77 [0.63; 0.95], p = 0.047) were protective factors. We identified 3 groups at risk: lower, average, and higher, respectively. A low threshold was characterized at 1.9% of 12-year risk and a high threshold at 4.5% 12-year risk. Mean 12-year risks in the 3 groups of risk were 1.37%, 2.68%, and 5.84%, respectively. Thus, 12% of women presented a level of risk different from the average risk group, corresponding to 600,000 women involved in the French organized BC screening, enabling to propose a new strategy to personalize the national BC screening. On one hand, for women at lower risk, we proposed to reduce the frequency of mammograms and on the other hand, for women at higher risk, we suggested intensifying surveillance.

摘要

在法国,有超过 1000 万名处于乳腺癌(BC)“平均”风险的女性被纳入了有组织的 BC 筛查中。现有的 BC 风险预测模型并不适用于法国人群。因此,我们在法国埃罗省建立了一个新的评分系统,并寻找处于“平均”风险的女性中不同风险级别的亚组。我们招募了一个回顾性队列的女性,年龄在 50 至 60 岁之间,她们接受了有组织的 BC 筛查,包括 2241 名非癌症女性和 527 名在 12 年随访期间(2006-2018 年)发展为 BC 的女性。确定的风险因素包括高乳腺密度(ACR BI-RADS 分级)(B 与 A:HR=1.41,95%CI [1.05;1.9],p=0.023;C 与 A:HR=1.65 [1.2;2.27],p=0.02;D 与 A:HR=2.11 [1.25;3.58],p=0.006)、母亲乳腺癌病史(HR=1.61 [1.24;2.09],p<0.001)和社会经济困难(HR 1.23 [1.09;1.55],p=0.003)。而早绝经(HR=0.36 [0.13;0.99],p=0.003)和初潮年龄在 12 年后(HR=0.77 [0.63;0.95],p=0.047)是保护因素。我们确定了 3 个风险组:低、中、高,分别为。低风险阈值为 12 年风险的 1.9%,高风险阈值为 12 年风险的 4.5%。3 个风险组的平均 12 年风险分别为 1.37%、2.68%和 5.84%。因此,12%的女性的风险水平与平均风险组不同,涉及到法国有组织的 BC 筛查的 60 万名女性,可以提出一种新的策略来个性化国家 BC 筛查。一方面,对于低风险的女性,我们建议减少乳房 X 光检查的频率,另一方面,对于高风险的女性,我们建议加强监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/8476568/a02c327bcce8/41598_2021_98604_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/8476568/77d6e9e269ac/41598_2021_98604_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/8476568/a02c327bcce8/41598_2021_98604_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/8476568/77d6e9e269ac/41598_2021_98604_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/8476568/a02c327bcce8/41598_2021_98604_Fig2_HTML.jpg

相似文献

1
Determination of thresholds of risk in women at average risk of breast cancer to personalize the organized screening program.确定平均乳腺癌风险女性的风险阈值,以实现有组织的筛查计划的个体化。
Sci Rep. 2021 Sep 27;11(1):19104. doi: 10.1038/s41598-021-98604-6.
2
The effect of organized breast cancer screening on mammography use: Evidence from France.法国的证据表明,有组织的乳腺癌筛查对乳房 X 光检查的使用有影响。
Health Econ. 2018 Dec;27(12):1963-1980. doi: 10.1002/hec.3813. Epub 2018 Aug 6.
3
Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.挪威实施有组织的基于人群的乳腺癌筛查后乳腺癌死亡率的变化。
J Natl Cancer Inst. 2020 Aug 1;112(8):839-846. doi: 10.1093/jnci/djz220.
4
Proportion of women with self-reported opportunistic mammography before organized screening.在有组织的筛查之前进行自我报告的机会性乳腺X线摄影检查的女性比例。
Acta Oncol. 2016 Jul;55(7):865-9. doi: 10.3109/0284186X.2016.1171392. Epub 2016 May 4.
5
Evaluation of the association between mammographic density and the risk of breast cancer using Quantra software and the BI-RADS classification.使用Quantra软件和BI-RADS分类评估乳腺密度与乳腺癌风险之间的关联。
Medicine (Baltimore). 2020 Nov 13;99(46):e23112. doi: 10.1097/MD.0000000000023112.
6
Benefits of the quality assured double and arbitration reading of mammograms in the early diagnosis of breast cancer in symptomatic women.在症状性妇女乳腺癌的早期诊断中,质量保证的双读和仲裁读乳腺 X 光片的益处。
Eur Radiol. 2012 May;22(5):1014-22. doi: 10.1007/s00330-011-2334-9. Epub 2011 Nov 18.
7
Investigation of the significance of population-based breast cancer screening among women aged under 40 years.40岁以下女性基于人群的乳腺癌筛查意义的调查。
Breast Cancer. 2021 Jan;28(1):75-81. doi: 10.1007/s12282-020-01131-x. Epub 2020 Jul 8.
8
Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.在奥地利蒂罗尔州引入乳腺钼靶筛查项目后晚期乳腺癌病例数减少。
Breast. 2017 Jun;33:178-182. doi: 10.1016/j.breast.2017.04.002. Epub 2017 Apr 15.
9
[Organized breast cancer screening].[有组织的乳腺癌筛查]
Bull Acad Natl Med. 2014 Feb;198(2):369-86.
10
Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.法国采用组织性或机会性乳腺癌筛查的女性特征。对2006年法国健康、医疗保健与保险调查的分析。
Rev Epidemiol Sante Publique. 2012 Dec;60(6):421-30. doi: 10.1016/j.respe.2012.05.006. Epub 2012 Nov 10.

引用本文的文献

1
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women.饮酒与乳腺病变:意大利高危女性基于风险筛查的目标
Breast Cancer. 2025 May 16. doi: 10.1007/s12282-025-01720-8.
2
Predicting Quality of Life in Women with Breast Cancer Who Engage in Physical Exercise: The Role of Psychological Variables.预测参与体育锻炼的乳腺癌女性的生活质量:心理变量的作用。
Healthcare (Basel). 2023 Jul 21;11(14):2088. doi: 10.3390/healthcare11142088.
3
Understanding the contribution of lifestyle in breast cancer risk prediction: a systematic review of models applicable to Europe.

本文引用的文献

1
Universal Genetic Testing to Identify Pathogenic Germline Variants in Patients With Cancer.通过全基因组检测识别癌症患者的致病性种系变异
JAMA Oncol. 2021 Jul 1;7(7):1070. doi: 10.1001/jamaoncol.2021.1002.
2
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.在接受筛查的致密型乳腺女性中,比较用于乳腺癌检测的简化乳腺 MRI 与数字乳腺断层合成术。
JAMA. 2020 Feb 25;323(8):746-756. doi: 10.1001/jama.2020.0572.
3
Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
了解生活方式对乳腺癌风险预测的贡献:适用于欧洲的模型系统评价。
BMC Cancer. 2023 Jul 21;23(1):687. doi: 10.1186/s12885-023-11174-w.
4
Breast cancer and physical activity: A bibliometric analysis.乳腺癌与身体活动:一项文献计量分析。
Front Oncol. 2023 Jan 12;12:1051482. doi: 10.3389/fonc.2022.1051482. eCollection 2022.
评估 Gail 模型预测乳腺癌风险的性能:系统评价和荟萃分析与试验序贯分析。
Breast Cancer Res. 2018 Mar 13;20(1):18. doi: 10.1186/s13058-018-0947-5.
4
Contemporary Hormonal Contraception and the Risk of Breast Cancer.当代激素避孕与乳腺癌风险。
N Engl J Med. 2017 Dec 7;377(23):2228-2239. doi: 10.1056/NEJMoa1700732.
5
The WISDOM Study: breaking the deadlock in the breast cancer screening debate.智慧研究:打破乳腺癌筛查辩论的僵局
NPJ Breast Cancer. 2017 Sep 13;3:34. doi: 10.1038/s41523-017-0035-5. eCollection 2017.
6
Multigene Panel Testing and Breast Cancer Risk: Is It Time to Scale Down?多基因检测与乳腺癌风险:是时候缩减规模了吗?
JAMA Oncol. 2017 Sep 1;3(9):1176-1177. doi: 10.1001/jamaoncol.2017.0342.
7
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.癌症易感性检测panel 基因与乳腺癌的相关性研究。
JAMA Oncol. 2017 Sep 1;3(9):1190-1196. doi: 10.1001/jamaoncol.2017.0424.
8
Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA).队列简介:卡罗琳斯卡乳腺癌风险预测乳腺X线摄影项目(KARMA)。
Int J Epidemiol. 2017 Dec 1;46(6):1740-1741g. doi: 10.1093/ije/dyw357.
9
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.乳腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2016 Feb 16;164(4):279-96. doi: 10.7326/M15-2886. Epub 2016 Jan 12.
10
A new reliable index to measure individual deprivation: the EPICES score.一种用于衡量个体贫困程度的新的可靠指标:EPICES评分。
Eur J Public Health. 2015 Aug;25(4):604-9. doi: 10.1093/eurpub/cku231. Epub 2015 Jan 25.